
Senator · IA · R
Current term Jan 3, 2023 – Jan 3, 2029 · In the Senate since Jan 5, 1981
Official websiteContact formBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 28, 2026. Only the current version of each report is used.
38,764 report citations, newest first.
CHEVRON U.S.A. INC. · lobbying firm or registrant: CHEVRON U.S.A. INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Foreign Relations
$2,770,000
Spent on own lobbying
CitesS. 1241· this member:Cosponsored
…ce agreement with Ukraine, violates any such agreement, or initiates another military invasion of Ukraine, and for other purposes; provisions related to energy S. 1241: Sanctioning Russia Act of 2025; provisions related to energy General Discussions Related to FOR (no specific Bill #): African Energy Issues American Energy Se…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHEVRON U.S.A. INC. · lobbying firm or registrant: CHEVRON U.S.A. INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Fuel/Gas/Oil
$2,770,000
Spent on own lobbying
CitesS. 593· this member:Cosponsored
H.R. 1346: Nationwide Consumer and Fuel Retailer Choice Act of 2025; all provisions S. 593: Nationwide Consumer and Fuel Retailer Choice Act of 2025; all provisions General Discussions Related to FUE (no specific Bill #): Energy Markets Compressed Na…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GRAIL LLC · lobbying firm or registrant: MILLER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
CitesS. 339· this member:Cosponsored
…multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GRAIL LLC · lobbying firm or registrant: MILLER STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$60,000
Paid to lobbying firm
CitesS. 339· this member:Cosponsored
…multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS CORPORATION · lobbying firm or registrant: SIEMENS CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Tariff (miscellaneous tariff bills)
$1,090,000
Spent on own lobbying
CitesH.R. 5334· this member:Recorded votes on 4 roll calls
…ctrical distribution equipment supporting US data center and manufacturing sectors; United States-Mexico-Canada Agreement (USMCA) renegotiation considerations; H.R.5334 - Lindsey O. Graham Sanctioning Russia and Iran Act of 2026, issues generally.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENCORA, INC. · lobbying firm or registrant: CENCORA, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$405,804
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…(H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act for Fiscal Year 2027 (NDAA - H.R.8800/S.4784) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to consumer pharmacy proposals CMS FY 2026 Medicare Part B Physician Fee Schedule Ru…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA ACTION · lobbying firm or registrant: FAMILIES USA ACTION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
Amount not reported
CitesS. 2355· this member:Cosponsored
Legislation to advance site neutral payments reforms S. 2355Patients Deserve Price Tags ActLegislation to strengthen and codify federal hospital and insurer transparency rules to ensure the publication of prices in dolla…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesH.R. 9340· this member:Recorded vote on 1 roll call
…uring and Establishing Consumer Uniform Rights and Enforcement over Data Act (SECURE Data Act); H.R. 8881, SBA Artificial Intelligence Utilization Act of 2026; H.R. 9340, Ratepayer Protection Act; S. 146, TAKE IT DOWN Act; S. 278, Kids Off Social Media Act; S. 836, Children and Teens Online Privacy Protection Act (COPPA 2.0); S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesS. 1748· this member:Cosponsored
…146, TAKE IT DOWN Act; S. 278, Kids Off Social Media Act; S. 836, Children and Teens Online Privacy Protection Act (COPPA 2.0); S. 1367, NO FAKES Act of 2025; S. 1748/H.R. 6484, Kids Online Safety Act (KOSA); S. 1792, AI Whistleblower Protection Act; S. 1829, STOP CSAM Act of 2025; S. 1885, Stop the Scroll Act; S. 2019, Task…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesS. 1792· this member:Sponsored
…dia Act; S. 836, Children and Teens Online Privacy Protection Act (COPPA 2.0); S. 1367, NO FAKES Act of 2025; S. 1748/H.R. 6484, Kids Online Safety Act (KOSA); S. 1792, AI Whistleblower Protection Act; S. 1829, STOP CSAM Act of 2025; S. 1885, Stop the Scroll Act; S. 2019, Taskforce for Recognizing and Averting Payment Scams (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesS. 1829· this member:Cosponsored
…Privacy Protection Act (COPPA 2.0); S. 1367, NO FAKES Act of 2025; S. 1748/H.R. 6484, Kids Online Safety Act (KOSA); S. 1792, AI Whistleblower Protection Act; S. 1829, STOP CSAM Act of 2025; S. 1885, Stop the Scroll Act; S. 2019, Taskforce for Recognizing and Averting Payment Scams (TRAPS) Act; S. 2081, Responsible Innovatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesS. 3397· this member:Sponsored
…(GUARD) Act of 2026; S. 3150, Guaranteeing Access and Innovation for National Artificial Intelligence (GAIN AI) Act of 2025; S. 3339, AI Workforce PREPARE Act S. 3397, Ending Coercion of Children and Harm Online (ECCHO) Act; S. 3774, Safeguarding Consumers from Advertising Misconduct (SCAM) Act; S. 3947, Reconductoring Exist…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES · lobbying firm or registrant: META PLATFORMS, INC. AND VARIOUS SUBSIDIARIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Computer Industry
$5,880,000
Spent on own lobbying
CitesS. 836· this member:Cosponsored
…R. 8881, SBA Artificial Intelligence Utilization Act of 2026; H.R. 9340, Ratepayer Protection Act; S. 146, TAKE IT DOWN Act; S. 278, Kids Off Social Media Act; S. 836, Children and Teens Online Privacy Protection Act (COPPA 2.0); S. 1367, NO FAKES Act of 2025; S. 1748/H.R. 6484, Kids Online Safety Act (KOSA); S. 1792, AI Whi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HEALTHCARE ASSOCIATION OF NYS · lobbying firm or registrant: HEALTHCARE ASSOCIATION OF NYS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$100,000
Spent on own lobbying
CitesS. 2355· this member:Cosponsored
…ider tax limitations from H.R. 1 Opposition to new non-profit hospital reporting requirements H.R. 9504, the Tax-Exempt Hospital Transparency Act Opposition to S. 2355, the Patients Deserve Price Tags Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOURCEAMERICA · lobbying firm or registrant: SOURCEAMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$80,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
H.R.8800 and S.4784, National Defense Authorization Act for Fiscal Year 2027, one percent procurement goal for the AbilityOne Program.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ABBOTT LABORATORIES · lobbying firm or registrant: ABBOTT LABORATORIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,300,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
S.2003 The Strengthening Benefit Plans Act of 2025. S.4784 The National Defense Authorization Act of 2027. Proposals related to pension premiums and employee benefits.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Spent on own lobbying
CitesS. 1041· this member:Cosponsored
…s, and for other purposes. S.1040Drug Competition Enhancement ActTo amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. S.1041Affordable Prescriptions for Patients ActTo amend title 35, United States Code, to address the infringement of patents that claim biological products, and for o…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Spent on own lobbying
CitesS. 1095· this member:Cosponsored
…ce and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. S.1095Stop STALLING ActTo enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Spent on own lobbying
CitesS. 1096· this member:Cosponsored
…to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. S.1096Preserve Access to Affordadable Generics and BiosimilarsTo prohibit brand name drug companies from compensating generic drug companies to delay the entry of a g…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Spent on own lobbying
CitesS. 1097· this member:Cosponsored
…scriptions for Patients ActTo amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1097Interagency Patent Coordination and Improvement Act of 2025To amend title 35, United States Code, to establish an interagency task force between the United Stat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Spent on own lobbying
CitesS. 527· this member:Sponsored
S.527Prescription Pricing for the People Act of 2025To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain an…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FAMILIES USA FOUNDATION INC · lobbying firm or registrant: FAMILIES USA FOUNDATION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$30,000
Spent on own lobbying
CitesS. 2355· this member:Cosponsored
…the United States, and for other purposes. HR6248Healthy Competition for Better Care Actlegislation to ban anticompetitive terms in insurer-provider contracts S. 2355Patients Deserve Price Tags ActLegislation to strengthen and codify federal hospital and insurer transparency rules to ensure the publication of prices in dolla…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
APPLE, INC. · lobbying firm or registrant: THOLOS GOVERNMENT RELATIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Labor Issues/Antitrust/Workplace
$60,000
Paid to lobbying firm
CitesS. 4746· this member:Sponsored
S. 4746 American Innovation & Choice Online Act; S. 2153 Open App Markets Act/H.R. 3209 App Store Freedom Act; Issues related to competition in digital markets and the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PRUDENTIAL FINANCIAL INC · lobbying firm or registrant: PRUDENTIAL FINANCIAL, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$499,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…tment of life insurance and annuities Taxation of Digital Assets International Tax (GILTI, Foreign Issued Contracts, OECD Pillar 2) One Big Beautiful Bill Act (H.R. 1)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PRUDENTIAL FINANCIAL INC · lobbying firm or registrant: PRUDENTIAL FINANCIAL, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$499,000
Spent on own lobbying
CitesS. 1335· this member:Cosponsored
Ordinary tax treatment of bonds (H.R. 2547/S. 1335) Tax treatment of life insurance and annuities Taxation of Digital Assets International Tax (GILTI, Foreign Issued Contracts, OECD Pillar 2) One Big Beautiful…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing